CYP3A5

E905090

CYP3A5 is a liver-expressed cytochrome P450 enzyme that metabolizes various drugs and xenobiotics, contributing to interindividual variability in drug clearance.

Jump to: Statements Referenced by

Statements (56)

Predicate Object
instanceOf cytochrome P450 enzyme
drug-metabolizing enzyme
enzyme
protein
affects calcineurin inhibitor pharmacokinetics
tacrolimus dose requirements
alleleCYP3A5*1 expressor allele
alleleCYP3A5*3 non-expressor allele
alleleCYP3A5*6 non-functional allele
alleleCYP3A5*7 non-functional allele
contributesTo first-pass metabolism of orally administered drugs
interindividual variability in drug clearance
encodedBy CYP3A5 gene NERFINISHED
foundInTaxon Homo sapiens NERFINISHED
hasAllele CYP3A5*1
CYP3A5*3 NERFINISHED
CYP3A5*6 NERFINISHED
CYP3A5*7 NERFINISHED
hasBiologicalProcess drug metabolic process
oxidation-reduction process
steroid metabolic process
xenobiotic metabolic process
hasCofactor heme
hasMolecularFunction drug binding
monooxygenase activity
oxidoreductase activity
highlyExpressedIn CYP3A5*1 carriers
inducedBy carbamazepine NERFINISHED
rifampin NERFINISHED
inhibitedBy azole antifungals
macrolide antibiotics
isClinicallyRelevantFor pharmacogenomics
isPolymorphic true
locatedIn adrenal gland
endoplasmic reticulum membrane
intestine
kidney
liver
lowOrAbsentExpressionIn CYP3A5*3 homozygotes
memberOf CYP3A subfamily NERFINISHED
cytochrome P450 superfamily NERFINISHED
metabolizes carbamazepine
cyclosporine
endogenous steroids
midazolam NERFINISHED
nifedipine NERFINISHED
protease inhibitors
statins
tacrolimus
orthologInHuman CYP3A5 NERFINISHED
regulatedBy constitutive androstane receptor NERFINISHED
pregnane X receptor NERFINISHED
requires NADPH
cytochrome P450 reductase NERFINISHED
subcellularLocation microsome
usesSubstrate lipophilic compounds

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

docetaxel primaryMetabolismEnzyme CYP3A5
subject surface form: Docetaxel